Adenovirus p53 gene therapy
- 22 December 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 6 (1) , 55-61
- https://doi.org/10.1517/14712598.6.1.55
Abstract
(2006). Adenovirus p53 gene therapy. Expert Opinion on Biological Therapy: Vol. 6, No. 1, pp. 55-61. doi: 10.1517/14712598.6.1.55Keywords
This publication has 35 references indexed in Scilit:
- The p53 pathway and apoptosisJournal of Cellular Physiology, 1999
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposideGene Therapy, 1998
- Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19Cell, 1997
- Parenteral Gene Therapy with p53 Inhibits Human Breast TumorsIn VivoThrough a Bystander Mechanism Without Evidence of ToxicityHuman Gene Therapy, 1997
- A novel form of Epstein-Barr virus latency in normal B cells in vivoCell, 1995
- Prognostic Significance of p53 andrasGene Abnormalities in Lung Adenocarcinoma Patients with Stage I Disease after Curative ResectionJapanese Journal of Cancer Research, 1994
- Therapeutic Effect of a Retroviral Wild-Type p53 Expression Vector in an Orthotopic Lung Cancer ModelJNCI Journal of the National Cancer Institute, 1994
- p53 expression and prognosis in gastric carcinomaInternational Journal of Cancer, 1992
- Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-OncogeneScience, 1990